Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma. Pereira JL, Arede L, Ferreira F, Matos A, et al. Leukemia 2024 Oct 25. doi: 10.1038/s41375-024-02446.

Read + Share

Amedeo Smart

Independent Medical Education

Pereira JL, Arede L, Ferreira F, Matos A, et al. Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma. Leukemia 2024 Oct 25. doi: 10.1038/s41375-024-02446.
PMID: 39455852